DKT WomanCare’s role in shaping the market for Levoplant in Africa
Last week, DKT WomanCare Global proudly participated in Development Innovation Insider’s webinar alongside the Shanghai Institute of Planned Parenthood Research, Dahua, and FHI 360 to demonstrate the impact of low-cost but high-quality Chinese-made contraceptives in Africa.
During the webinar DKT’s Marketing Director True Overholt shared the success story of the contraceptive implant Levoplant, manufactured near Shanghai by Dahua. Now distributed in over 30 countries mostly in Africa, the presentation shared how DKT uses #socialmarketing to bring Levoplant from the factory all the way to the user and highlighted Levoplant’s global growth and its importance in preserving access and choice in several key countries. The presentation ended with testimonials from four Levoplant users, who cited its long-duration, effectiveness, and “peace of mind to enjoy unprotected sex freely without fear” #pleasuree) as the main benefits.
More information about Levoplant: https://dktwomancare.org/providers-contraception/levoplant-contraceptive-implants
PRESS
- How One Social Marketing Organization Is Transitioning From Charity to Social Enterprise
- Closing the loop. DKT WomanCare is a step along the path of giving men and women complete control of their reproductive health.
- Opinion: For women in conflict settings, family planning services are often first to go
- How Bangladesh Made Abortion Safer
- What it is like to have unsafe abortion
- VIEW ALL
CORPORATE NEWS
- Closing the loop. DKT WomanCare is a step along the path of giving men and women complete control of their reproductive health.
- DKT WomanCare Global Announces Ipas Manual Vacuum Aspiration(MVA) Technology Price Reduction for All FP2020 Focus Countries
- DKT WomanCare Global Signs Distribution Agreement with IUD manufacturer Pregna International Ltd. for Twelve Countries
- Creating a sustainable supply of MVA instruments in humanitarian settings
- How the Ipas MVA preserves #AbortionCare services amid COVID-19
- VIEW ALL